CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway
Based on our findings, we propose a novel mechanism by which CD151 mediates tumor progression through the initiation of EMT. This suggests that CD151 could be considered a potential therapeutic target for TNBC.
Authors
- Youjia Li (ORCID: https://orcid.org/0000-0002-4755-679X)
- Chao Deng (ORCID: https://orcid.org/0000-0002-3672-0056)
- Rui Wang (ORCID: https://orcid.org/0009-0006-0589-2062)
- Lei Shi (ORCID: https://orcid.org/0000-0003-4937-9624)
- Huifang Lv (ORCID: https://orcid.org/0000-0003-0008-3961)
- Bei-bei Zhang (ORCID: https://orcid.org/0009-0007-5462-8417)
- Yuanqin Yin
- Xurong Weng
Institutions
- Fourth Affiliated Hospital of China Medical University (CN)
- First Hospital of China Medical University (CN)
- Liaoning Cancer Hospital & Institute (CN)
- China Medical University (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/bctt.s518760
- Citations
- 2
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 3.24
Funders
- National Natural Science Foundation of China
- China Medical University